President Biden is expected to announce Wednesday a plan to fight opioid addiction.
The plan is expected by the end of the day.
Biden will deliver the news during a White House news conference, which will be streamed live on the White House website and the CBS News app.
Biden plans to announce a plan, along with several other steps, to combat the opioid epidemic, including expanding access to treatment, making it easier for addicts to access medication and providing incentives to businesses to help curb opioid sales.
In addition, Biden plans a call with congressional leaders and the National Governors Association to discuss the opioid crisis, which is already the highest number of deaths and overdoses of any president since World War II.
President Biden says he will use the opportunity to focus on the opioid scourge.
“It’s not a problem.
It’s a national crisis,” Biden told reporters.
Biden has been working closely with Congress to try to curb the epidemic.
In July, Biden and Republican leaders in the House and Senate passed the opioid addiction bill, known as the Prevention and Treatment of Drug Overdose Prevention Act.
That legislation would help states expand treatment programs, which would help those suffering from addiction to get the treatment they need.
In the weeks since the bill passed, more than 700 Americans have died of opioid overdoses.
In 2016, a report by the U.S. Centers for Disease Control and Prevention found that drug overdoses are the leading cause of death for Americans over age 65, accounting for more than one-third of all deaths.
That report also found that opioids are responsible for more overdose deaths than any other drug.
The Trump administration is also expected to launch a new strategy to combat opioid addiction during Biden’s news conference.
That strategy, which was announced in June, calls for the president to push for states to create and enforce safe and legal alternatives to opioids and other opiates, as well as provide incentives for businesses to reduce opioid sales, a strategy that will likely be supported by the opioid industry and the Trump administration.